Comments
Novartis CEO keen to keep dividend, big M&A not likely: paper
08.10.2012. | ZURICH (Reuters) - Novartis is keen to maintain its dividend and is looking to boost growth via mid-sized acquisitions, though big deals are unlikely, the Swiss drugmaker's chief executive said in a newspaper interview on Sunday....
